Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis

Psoriatic arthritis (PsA) is an inflammatory arthritis that affects many psoriasis patients and can often have a debilitating disease progression. Golimumab is a new tumor necrosis factor (TNF) antagonist recently approved by the FDA for controlling signs and symptoms of psoriatic arthritis. In a Ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelon, Melissa A, Gottlieb, Alice B
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047949/
https://www.ncbi.nlm.nih.gov/pubmed/21437062

Ejemplares similares

Ejemplares similares